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Abstract
Background: The primary aim of this study is to evaluate the effectiveness of different doses (intensity) of supervised
exercise training — concomitant with lifestyle counselling — as a primary care intervention tool for the management
of metabolic syndrome risk factors in low-active adults with one or more such factors (programme name in Catalan:
Bellugat de CAP a peus).
Methods/Design: Three-arm, randomized controlled clinical trial implemented in the primary care setting, with a
duration of 40 weeks (16 weeks intervention and 24-week follow-up).
Adults aged 30 to 55 years with metabolic risk factors will be randomized into three intervention groups: 1) aerobic
interval training (16 supervised training lessons) plus a healthy lifestyle counselling programme (6 group and 3 individual
meetings); 2) low-to-moderate intensity continuous training (16 supervised training lessons) plus the same counselling
programme; or 3) the counselling- programme without any supervised physical exercise.
The main output variables assessed will be risk factors for metabolic syndrome (waist circumference, blood pressure, and
levels of plasma triglycerides, high-density lipoproteins and glucose), systemic inflammation, cardiorespiratory
fitness, physical activity and sedentary behaviour, dietary habits, health-related quality of life, self-efficacy and
empowerment. Economic factors will also be analysed in order to determine the cost-effectiveness of the programme.
These variables will be assessed three times during the study: at baseline, at the end of the intervention, and at follow-
up. We estimate to recruit 35 participants per group.
Discussion: The results of this study will provide insight into the immediate and medium-term effects on metabolic risk
and lifestyle of a combined approach involving aerobic interval training and a multidisciplinary behavioural intervention.
If effective, the proposed intervention would provide both researchers and practitioners in this field with a platform on
which to develop similar intervention programmes for tackling the repercussions of an unhealthy lifestyle.
Trial registration: Clinical trials.gov. NTC02832453. Registered 6 July 2016 (retrospectively registered).
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Background
Metabolic syndrome consists of a cluster of risk factors
for cardiovascular disease that comprises abdominal
obesity, impaired glucose tolerance, hypertension and
dyslipidemia. When these factors appear together the
cardiovascular risk rises substantially. In Spain, the
prevalence of metabolic syndrome is 42.1% in men and
32.3% in women, and it increases with age [1].
A considerable body of epidemiological evidence indi-
cates that the most prevalent diseases in developed soci-
eties, including metabolic syndrome, are closely linked
to lifestyle factors, notably smoking, unhealthy dietary
habits, physical inactivity and stress. The increasing
prevalence of metabolic syndrome and its negative im-
pact on individuals and society has been mainly attrib-
uted to a decline in regular physical activity, an increase
in sedentary behaviour and changes in dietary habits.
Given that these factors are all modifiable they may be
reversed through interventions focussing on behavioural
change. Changes in lifestyle can have a positively effect
on the prevalence of cardiovascular risk factors and,
therefore, on that of metabolic syndrome and cardiovas-
cular diseases [2].
In an attempt to tackle the problem of unhealthy life-
styles, the World Health Organisation (WHO) developed
a Global Strategy on Diet, Physical Activity and Health,
the aim of which was to control and prevent non-
communicable diseases or their risk factors [3]. Physical
activity has a key role to play in any such strategy. How-
ever, despite investment in the promotion of physical ac-
tivity, the degree to which people engage in regular weekly
exercise remains worryingly low. According to the Special
Eurobarometer 412 [4], 54% of European Union citizens
interviewed had not, during the previous week, done any
physical activity of vigorous intensity, and 44% had not
done any exercise of moderate intensity. In addition to the
lack of moderate-to-vigorous physical activity, about two-
thirds (69%) of respondents also stated that they spent be-
tween 2.5 and 8.5 h sitting during waking hours, and 11%
sat for more than 8.5 h.
The health benefits of regular physical exercise in terms
of preventing and treating many non-communicable dis-
eases are well-established [5]. They include positive effects
on single metabolic risk factors, such as normalization of
blood pressure and improvements in body composition,
hyperlipidaemia and insulin resistance [5]. Physical exer-
cise also increases cardiorespiratory and muscular fitness.
Regarding metabolic syndrome as a whole, Pattyn and
colleagues [6] recently conducted a meta-analysis and
concluded that dynamic physical exercise has beneficial
effects on the majority of metabolic risk factors (abdom-
inal obesity, high-density lipoprotein cholesterol (HDLc),
systolic and diastolic blood pressure), as well as on other
factors such as body mass index (BMI) or maximal oxygen
uptake (VO2max). However, they also highlight that the
most favourable modality/dose of exercise (dynamic
versus static; low-to-moderate intensity versus high in-
tensity) has yet to be fully elucidated.
Present guidelines for physical exercise as a healthy be-
haviour are based around continuous training methods
(30–60 min/session, low-to-moderate intensity, 2–7 ses-
sions per week) [5, 7, 8]. The WHO [9] recommends that
individuals aged 18–65 should accumulate a minimum of
150 min per week of moderate-intensity physical activity
or, alternatively, 75 min per week of vigorous physical ac-
tivity, or a combination of both.
However, although moderate-intensity exercise is suf-
ficient to reduce cardiovascular risk, it has been sug-
gested that higher intensity exercise offers greater benefits
[10–12]. Accordingly, the health setting has recently
witnessed a growing interest in interval training
methods, particularly high-intensity interval training
(HIIT). When the aim of this method is to stimulate
preferentially the aerobic system over the anaerobic
one, it is referred to as aerobic interval training [13].
Aerobic interval training (AIT) consists of repeated
bouts, either short (<45 s) or long (1 to 8’), of fairly
high-intensity exercise (equal or superior to the max-
imal lactate steady-state velocity) interspersed with re-
covery periods.
To date, several studies have analysed the effects of
AIT in individuals with cardiovascular risk factors or
with diseases such as metabolic syndrome, ischaemic
cardiopathy or cardiac insufficiency. Results from these
studies suggest that AIT produces a greater improvement
in VO2max than does traditional continuous training
(TCT). The effect has been described in recreationally ac-
tive individuals [14], as well as in patients with coronary
artery disease [15–17] or metabolic syndrome [18, 19]. It
has also been shown that AIT reduces the prevalence of
metabolic risk factors [15, 17, 19, 20]. The positive effects
of AIT on metabolic risk factors involve changes in body
composition, ventricular and vascular functions, plasmatic
adiponectin and glucose intolerance. Studies comparing
the effects of different training methods generally re-
port better results after AIT and suggest that this
method optimizes the time necessary to induce mus-
cular, metabolic and cardiorespiratory effects in the
medium and long term [17, 19, 20].
Although these studies support the efficacy of AIT for
reducing metabolic risk factors, its effectiveness has yet
to be fully demonstrated. One of the difficulties faced
when seeking to replicate in practice the evidence
obtained in controlled studies is that individuals are
less constrained and become more responsible for their
own compliance with physical exercise. As Rankin [10]
states, physical exercise will have no benefits unless the in-
dividual actually does it. Accordingly, there is evidence to
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suggest that the most effective interventions, among those
aiming to promote healthier behaviour, are those that not
only involve scheduled physical activity and exercise but
which also offer lifestyle counselling, including advice
on dietary habits and how to reduce daily sedentary
time, along with tools that can empower individuals to-
wards behaviour change.
Detractors of high intensity exercise claim that HIIT is
not an appropriate or sustainable form of exercise for
public heath guidelines because it is unlikely to induce
changes in the population as a whole [21]. It is argued
that HIIT will be associated with negative feelings and
lack of enjoyment, leading therefore to poor compliance.
Biddle, for example, claims that as a public health tool,
higher intensity exercise may not be better if people are
less willing to do it [21]. However, AIT is a form of HIIT
in which exercise intensity is not maximal. This feature
may explain why, contrary to what might be expected
given the low physical condition of the participants in
some studies, AIT sessions have been well tolerated by
sedentary individuals with or without concomitant dis-
eases [17, 19, 20, 22, 23]. Indeed, no adverse effects have
been reported [10], even in patients with heart failure
[12], because the intensity is tailored to the individual.
In addition, participants in AIT interventions report
greater satisfaction than do people in TCT interventions.
This could be attributable to the variable nature of the
session, in comparison with the monotony of TCT
sessions, as well as to the fact that the intensity of in-
tervals promotes a greater sense of challenge. These as-
pects reflect the potential of AIT to improve adherence
to exercise interventions [23]. Although in some indi-
viduals AIT may trigger a feeling of displeasure and,
hence, impair their confidence and adherence [21], fac-
tors such as the optimization of time spent on training
sessions and the associated satisfaction of participants
may contribute to the consolidation and long-term per-
sistence of an active lifestyle.
To our knowledge, although the efficacy of AIT in rela-
tion to cardiometabolic risk factors has been established
in several studies, there are no data on the effectiveness of
AIT when implemented in conjunction with lifestyle
counselling as an intervention in the primary care setting.
The primary aim of this study is to evaluate the effective-
ness of different doses (intensities) of supervised exercise
training (AIT and TCT), both concomitant with lifestyle
counselling, and to compare this with lifestyle counselling
(COU) alone as a primary care intervention tool for the
management of metabolic syndrome risk factors in
low-active adults with one or more such factors.
Secondary aims of the study are to investigate the ef-
fects of these interventions on systemic inflammation
and adipose tissue function, cardiorespiratory fitness,
physical activity and sedentary behaviour, dietary habits,
empowerment related to health, self-efficacy in relation
to physical activity and dietary habits, as well as the
cost-effectiveness of the intervention with regard to
health-related quality of life.
The study will also provide insights into the extent to
which any observed changes persist in the medium term.
The general hypothesis is that among adults with risk
factors for metabolic syndrome, those who participate in
interventions designed to promote a healthy lifestyle
through a combination of lifestyle counselling and su-
pervised physical exercise of vigorous intensity will
present greater improvements in terms of metabolic risk,
physical condition, physical activity/sedentary behaviours
and psychological parameters at the end of the interven-
tion and at 24-week follow-up than will participants in
interventions that combine lifestyle counselling with
physical exercise of low-to-moderate intensity or those
based exclusively on lifestyle counselling.
Methods
Trial design
This is a three-arm (dose–response exercise) randomized
controlled clinical trial implemented in the primary care
setting over a period of 16 weeks and with 24-week
follow-up (Fig. 1).
The study will include two supervised exercise groups
with two different doses of exercise intensity (AIT and
TCT), and a non-exercise control group (COU). All
groups will be given lifestyle counselling.
Participants
Eligibility criteria of participants
To be eligible, individuals should meet all the following
inclusion criteria and none of the exclusion criteria.
Inclusion criteria
– 30 to 55 years-old.
– Having one or more risk factors for metabolic
syndrome1 (waist circumference >94.5 cm for men
and >89.5 cm for women; blood pressure ≥130/
85 mmHg; triglycerides in plasma ≥150 mg/dL;
HDLc in plasma <40 mg/dL for men and <50 mg/dL
for women; fasting glycaemia ≥100 mg/dL).
– Low active (achieving less than 150 min/week of
moderate-to-vigorous physical activity or to have not
participated in any supervised exercise programmes
for at least the last 24 weeks).
– Accept and sign written informed consent.
– Accept the randomized group assignment.
Exclusion criteria
– Morbid obesity (BMI ≥ 40).
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Fig. 1 Bellugat flow chart
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– A past/current history and/or evidence through
physical examination or laboratory findings of
significant cardiovascular, respiratory, neuromuscular
or psychiatric disease/disorder.
– Diseases/disorders that may contraindicate
performing physical exercise or a stress test [7].
Enrolment, screening and allocation
Participants will be recruited through primary health-
care centres, including physician referrals and adver-
tisements through the media, community centres and
electronic mailing. Interested individuals will be in-
vited to an information session, where an in-depth
detailed explanation of the study requirements and
expectations will be given. Any questions will be
answered and doubts clarified. Potential eligibility will
be checked/confirmed by interview, obtaining information
about age, past and current physical activity, medical
history and medication use. Eligible participants who
wish to participate in the study will be asked to sign
written informed consent.
After providing written informed consent individuals
will be given an identification number. Participants will be
allocated to one of the two supervised physical exercise
groups (AIT or TCT) or to the control group (COU),
using a computer generated randomized list which allo-
cates at random the identification number of the par-
ticipant to a treatment group. The allocation sequence
will be generated by the IDIAP and will be conducted
without influence of the principal investigators.
Blinding
Due to the nature of the intervention, blinding of partic-
ipants will not be possible as each of them will be aware
of the kind of physical exercise they are engaged in.
However, during data analysis researchers will be blinded
to the intervention allocated to each participant.
Sample size
At least 105 individuals will be recruited for this study.
Based on previous studies [20], a sample of this size
would provide a beta risk of 0.2 and an alpha risk of
0.05 when using a bilateral contrast to detect a mean
change in waist circumference of 6.0 cm (SD 5.3). As-
suming a 20% drop-out rate at follow-up, we aim to re-
cruit 35 individuals for each intervention group.
Ethical implications
The study will be carried out in accordance with the
principles of the Declaration of Helsinki, and subsequent
revisions, as well as with the Guidelines for Good Prac-
tice in Primary Care Research of the Jordi Gol Primary
Care Research Institute (IDIAP).
The research protocol has been reviewed and approved
(P15/122) by the Institutional Board (CEIC) of the IDIAP,
and written informed consent will be obtained from all
participants prior to their inclusion in the study. Specific-
ally, all individuals will give their written informed consent
in accordance with the principles of the Declaration of
Helsinki and the dispositions established in Spanish law
(Chapter II, article 7, Royal Decree 223/2004 of 6 February
2004); the consent form will specify that participation in
the study is voluntary and that participants may withdraw
at any time. This information will be provided both orally
and in writing.
In this study, only researchers and health care profes-
sionals will have access to participants’ data.
The study methods are consistent with the CONSORT
guidelines for the reporting of randomized trials [24].
Trial intervention
The total duration of the trial will be 40 weeks, com-
prising a 16-week intervention phase and follow-up
24 weeks later. During the intervention phase all
groups (AIT, TCT and COU) will be offered lifestyle
counselling, alongside which the two exercise groups
(AIT and TCT) will take part in a supervised physical
exercise programme.
Counselling programme
The counselling programme consists of six, 50-min
group sessions and three individual sessions lasting 40–
50 min each. All these sessions will be conducted at the
primary healthcare centre by a nurse trained in physical
activity, nutrition and psychological strategies for behav-
iour change. An interactive participants’ guide has been
published with the aim of reinforcing the counselling
programme [25]. As a general rule, participants will be
required, before the sessions, to read certain information
(reports or chapters from the guide) or to reflect on the
process of behaviour change. These aspects will then be
discussed during the group or the individual meetings.
Table 1 shows a detailed outline of the aims and activ-
ities of these meetings.
Group counselling sessions Group sessions involving
no more than 10 participants will be scheduled with the
aim of providing counselling on a healthy lifestyle, in-
cluding physical activity, sedentary behaviour and
dietary habits. Strategies for behaviour change will
also be introduced as a way of empowering partici-
pants. Additionally, these sessions will give partici-
pants the opportunity to receive peer support.
Individual sessions The aim of the individual sessions
will be to focus in greater depth on each participant’s
needs. The professional will help the participant to
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Table 1 Aims and activities of healthy lifestyle counselling sessions for all interventions
N Aims of the session Example of meeting activities/actions (Participant actions unless otherwise specified)
1st Group Session
(week 1)
To explain the programme
To connect with the rest of
the group and establish the
dynamics of the meetings
To become aware of the
benefits of a healthy lifestyle
To establish personal goals




1. Browse the BELLUGA’T guide promoting a healthy lifestyle.




1. Present the programme: structure, dates, goals, strategies, etc.
2. Introduce ice-breaker and rapport-building activities.
Participant’s action:
1. Discuss beneficial effects of a healthy lifestyle.
2. Propose actions to reduce time spent in sedentary behaviours.
After the
session
1. Read the guide’s article about encouraging a healthier lifestyle.
2. Establish personal goals to reduce time spent in sedentary behaviors,




To become aware of the effect
of his/her cardiovascular risk
factors on his/her health status
To establish personal goals for
controlling his/her risk factors
and plan for the actions





1. Email results of baseline tests within 48 h of 1st session.
Participant’s action:
1. Read reports of basal tests.
2. Read the guide’s article about metabolic risk factors.
During the
session
1. Discuss reports with the leader.
2. Discuss personal risk factors and establish personal goals for the short
(2 weeks), mid (16 weeks), and long term (40 weeks).
3. Select actions to achieve personal goals to reduce metabolic risk factors.
After the
session
1. Place actions needed to achieve risk factor goals in a visible place and
start putting them into practice.
2nd Group Session
(week 4)
To become aware of the
importance of a good workout




1. Read guide’s article about increasing physical activity.





1. Provide information about ways to achieve a physically active lifestyle.
2. Present specific information about training, hydration, and stretching.
3. Introduce digital resources to help participants be more active.
Participant’s action:
1. Discuss beneficial effects of physical exercise in addition to routine
physical activity.
2. Brainstorm examples of physical activities and exercise programmes
After the
session
1. Establish physical activity plan to be more active at work and in spare
time in the next week.
2. Record physical activity in the smartphone application (app) or on paper.
3rd Group Session
(week 7)
To become aware of the
possibilities of exercising at
home, at work and in spare
time using everyday items









1. Demonstrate aerobic and strength exercises using stretch bands,
dumbbells and improvised exercise material.
Participant’s action:
1. Work on aerobic and strength exercises with improvised materials.




1. Review the video of the aerobic and strength exercises practiced in
class.
2. Establish physical exercise goals and record them in the app or on
paper.
4 rd Group Session
(week 10)
To become aware of the
importance of good nutrition








1. Provide nformation about healthy benefits of healthy eating.
2. Present the healthy food pyramid and the Mediterranean diet concept.
Participant’s action:
1. Discuss the beneficial effects of healthy nutrition.
2. Brainstorm different ways of making healthy food choices.
After the
session
1. Identify unhealthy food choices made and record them in the app
or on paper.
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establish realistic daily goals for physical activity and
will involve him/her in the decision-making process.
The session will be based on the transtheoretical
model of behaviour-change [26] and on motivational
interviewing [27].
Supervised physical exercise
The supervised exercise programme will be offered to
both exercise groups (AIT and TCT) and will consist of
16 supervised group training sessions lasting 50 min
each and 32 non-supervised individual training sessions
(i.e. self-administered by each participant).
The supervised training sessions will be run by experts
in physical exercise (sports centre based), who will also
deliver the instructions for the self-administered sessions.
Structure of the training sessions All training lessons
will comprise five parts: introduction (aims and contents),
warm-up, main part (differing between the AIT and
TCT groups, see below), cool-down, and stretching




To assess the current routine
of physical activity and
exercise and establish new
strategies if necessary
To become aware of the effect
of good nutrition on his/her
health status
To establish personal
nutritional goals and the





1. Email results of baseline dietary habits questionnaire within 48 h
of 2nd session.
Participant’s action:
1. Carry out a self-assessment of the establishment of physical
activity/exercise goals and the progress made.
2. Read report of baseline dietary habits questionnaire.
3. Read the guide’s article about strategies to overcome nutritional barriers.
During the
session
1. Review progress and resolve problems or setbacks in active lifestyle
goal-setting and action planning.
2. Highlight positive changes and define potential ways forward,
building on successes.
3. Discuss the dietary habits report with the leader and agree on
personal goals.
4. Identify possible barriers to healthy eating and select
actions/strategies to overcome them.
After the
session
1. Develop physical activity and exercise plan for the upcoming weeks.
2. Place actions needed to achieve active lifestyle goals in a visible
place and start putting them into practice.
6rd Group Session
(week 16)
To become aware of barriers
to new activity and nutritional
behaviors and devise
strategies to overcome them
To establish new strategies to
overcome barriers and




1. Read guide’s article about other healthy habits such as sleep and rest,
reduce stress, no smoking, etc.




1. Provide information about maintaining a healthy lifestyle.
2. Resolve doubts and facilitate access to additional resources that
may be needed.
Participant’s action:
1. Share strategies to overcome barriers to new active lifestyle and
dietary habits.




1. Review materials, acquired knowledge and strategies.




To become aware of the
effects of oneself new lifestyle
on reducing
cardiovascular risk factors
To establish new weekly





1. Email results of post-intervention tests within 48 h of 1st session.
Participant’s action:
1. Read the email reports of post-intervention results.




1. Analyse progress based on 16-week follow-up report after 16 weeks)
and resolve problems or setbacks.
2. Highlight positive changes and discuss potential ways forward.
3. Agree on relapse prevention plans (active lifestyle and healthy eating)
for the next 6 months.
After the
session
1. Maintain a new healthy lifestyle.
2. Keep a log of physical activity/exercise and eating habits, supported
by the BELLUGA’T app.
3. Consult the programme guide, other educational material provided,
and physical activity or primary healthcare professionals, as needed.
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and conclusions (instructions for self-administered
sessions).
The main part will differ between groups and consists of:
▪ AIT group: Four series of 4 min of cycling at a heart
rate of 80% of the VO2peak registered previously during
the stress test, with active pauses of 2 min at 60% of
the VO2peak between them (Table 2).
Given that maintaining the anticipated exercise intensity
might, at the beginning of the programme, excessively
burden participants allocated to this group, the length of
the series will be shorter during the initial sessions. Thus,
intensity will be established at 80% of the VO2peak but
series will last for 1 min during the first week, after which
they will be increased by 1 min each successive week until
reaching a duration of four minutes. At the same time,
active pauses will be shortened so as to accumulate an
exercise time of 24 min in that part of the session.
▪ TCT group: Participants allocated to this group will
perform activities such as walking, cycling, team
activities and toning exercises, always at an intensity
of 60% of their VO2peak. The number of training
sessions per week and the ratio of supervised to
self-administered sessions will be the same as that
shown in Table 2 for the AIT group.
Programme monitoring Both training groups will
perform the first eight sessions using indoor cycling
ergometers, another four lessons using a treadmill
and the remainder in outdoor green areas of the city.
Across the sixteen sessions participants will be able to
practise and to become familiar with a variety of exercise
forms, while keeping to the training goals. The aim is that
this experience allows them to feel more empowered with
respect to physical activity.
At the beginning of the programme, participants will
be given a heart rate monitor (Geonaute, ONRhythm
110, Oxylane, Villeneuve d’Ascq, France) that will be
used to monitor the training intensity during supervised
and self-administered sessions.
Additionally, a web-based application will be used to
monitor and provide feedback for the self-administered
training sessions.
Educational resources
Educational resources for supporting the counselling
programme, such as the participants’ guide [25], have
been validated by means of Delphi qualitative techniques
[28], patient interview, quantitative questionnaires [29, 30]
and the INFELZ software [31].
Outcome measures
Measurements will be taken before (t0 = 0 months) and
after (t1 = 16 weeks) the intervention. As a medium-
term follow-up measure, the exercise and control groups















1 2/1 16 × 1’ 80 30” 24’
2 2/1 8 × 2’ 80 1’ 24’
3 2/1 5 × 3’ 80 2’ 25’
4 2/1 4 × 4’ 80 2’ 24’
5 1/2 4 × 4’ 80 2’ 24’
6 1/2 4 × 4’ 80 2’ 24’
7 0/3 4 × 4’ 80 2’ 24’
8 1/2 4 × 4’ 80 2’ 24’
9 1/2 4 × 4’ 80 2’ 24’
10 0/3 4 × 4’ 80 2’ 24’
11 1/2 4 × 4’ 80 2’ 24’
12 1/2 4 × 4’ 80 2’ 24’
13 0/3 4 × 4’ 80 2’ 24’
14 1/2 4 × 4’ 80 2’ 24’
15 0/3 4 × 4’ 80 2’ 24’
16 1/2 4 × 4’ 80 2’ 24’
AIT aerobic interval training; n, number, Rep repetitions, VO2peak, peak oxygen uptake
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will also be assessed 24 weeks later (t2) (Fig. 1). Table 3
shows a detailed outline of the outcome measurements.
All assessments will be divided into two appointments.
In the first appointment, fasting blood samples will be
drawn through an antecubital vein, and anthropometric
(body mass, height, waist and hip circumferences) and
body composition measures (percentage of fat) will be
obtained. Also during this appointment, accelerometers
will be positioned on the participants’ waist and they
will be given instructions on how to complete an ac-
tivity log during the 7-day period that they will wear
the accelerometers.
Table 3 BELLUGAT protocol schedule form and procedures for all interventions
Time point Enrolment Baseline assessment Allocation +16 weeks assessment +24 weeks assessment






Body mass ✔ ✔ ✔
Height ✔ ✔ ✔
Body mass index ✔ ✔ ✔
Waist circumference ✔ ✔ ✔
Hip circumference ✔ ✔ ✔
Blood sampling and biochemical measurements
Lipid profile (TG, TC, HDLc, LDLc) ✔ ✔ ✔
Plasma glucose ✔ ✔ ✔
Plasma glycated haemoglobin ✔ ✔ ✔
Plasma adiponectin ✔ ✔ ✔
Plasma Interleucin-6 ✔ ✔ ✔
Plasma metabolome-lipidome ✔ ✔ ✔
Plasma MicroRNA ✔ ✔ ✔
Medical procedures
Resting blood pressure ✔ ✔ ✔
Cardiorespiratory fitness (VO2peak) ✔ ✔ ✔
Physical activity and sedentary behaviour
Physical activity (LPA and MVPA) ✔ ✔ ✔
Sedentary time ✔ ✔ ✔
Self-reported Questionnaires
Food frequency questionnaire ✔ ✔ ✔
Healthy eating index ✔ ✔ ✔
Empowerment related to health ✔ ✔ ✔
Physical activity and dietary habits self-efficacy ✔ ✔ ✔




Enjoyment with the programme ✔
Reasons for abandoning ✔ ✔ ✔
EQ-5D EQ-5D questionnaire, HDLc High Density Lipoprotein cholesterol, LDLc Low Density Lipoprotein cholesterol, LPA Light Physical Activity, miRNA microRNA,
MVPA Moderate-to-Vigorous Physical Activity, TC Total Cholesterol, TG Triglycerides, VO2peak Peak Oxygen uptake
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In the second assessment appointment, participants
will be asked to complete the questionnaires on health-
related quality of life, self-efficacy, empowerment and
dietary habits. Resting (recumbent and sitting) ECG and
blood pressure measures will then be taken. Finally, par-
ticipants will also complete a voluntary maximal graded
test on a cycle ergometer.
Accelerometers will be retrieved at the end of the 7-
day period during which participants have recorded their
free-living movement.
Risk factors for metabolic syndrome
Anthropometry and visceral adiposity Body mass
(precision: 0.1 kg) and height (precisions (0.1 cm) will
be measured with a scale (SECA 711, Hamburg,
Germany) and stadiometer (Año-Sayol, Barcelona,
Spain), with the participant in underwear and bare-
foot, following standard procedures [32]. Body mass
index (BMI) will be calculated by dividing body mass
(kg) by height (m2).
Waist circumference (WC) (precision: 0.1 cm) will be
measured in triplicate at the end of several consecutive
natural breaths, at a level parallel to the floor, at the
midpoint between the top of the iliac crest and the lower
margin of the last palpable rib in the mid-axillary line.
Hip circumference (HC) (0.1 cm) will also be measured
in triplicate at a level parallel to the floor, at the largest
circumference of the buttocks. Both measures will be
made with a stretch‐resistant tape and without constrict-
ing [33]. The mean of the three measurements will be
used in the waist-to-hip ratio calculation (WtHr).
Blood pressure Blood pressure (BP) will be measured
at the level of the brachial artery of the dominant arm
using an automated device (Omron M, Omron
Healthcare Europe B.V. Hoofddorp, The Netherlands),
with participants in a relaxed sitting position. Mea-
surements will be taken in duplicate, 2 min apart. The
latter of these will be recorded [34].
Plasma biochemistry Blood samples for the determin-
ation of plasma triglycerides (TG), total cholesterol
(TC), low-density lipoprotein cholesterol (LDLc), high-
density lipoprotein cholesterol (HDLc), glycated haemo-
globin (HbA1c) and glucose will be drawn after an over-
night fast, with participants in a sitting position. Blood
samples will be analysed with automated methods at the
laboratory of the Arnau de Vilanova University Hospital
(Lleida).
Metabolic risk score
A continuous metabolic syndrome risk score (cMSSy)
will be calculated, as described by Wijndaele [35]. The
score contains the five risk factors considered in the
definition of metabolic syndrome [1, 36], namely waist
circumference, TG, HDLc, systolic blood pressure (SBP)
and plasma glucose.
Systemic inflammation and adipose tissue parameters
Fasting blood samples will also be used to determine in-
flammation parameters (adiponectin and interleukin (IL)-
6). Inflammation parameters will be measured by immune
assay using high sensitivity MILLIPLEX®XMap commer-
cial kits (Millipore, Billerica, MA, USA). The visceral adi-
pose tissue index will be calculated following the
procedure described by Amato [37]; which relates waist
circumference, body mass index, triglycerides and HDLc.
Plasma microRNA determination
We will analyse miR-197, miR-23a, miR-509-5p, miR-
130a-b, miR-195, miR-27a and miR-320, which are known
to be deregulated and associated with features of meta-
bolic syndrome. Targeted microRNA will be determined
after its extraction from blood samples, following the in-
structions provided with the MagMax mirVana RNA iso-
lation kit. In addition, any microRNA will be quantified by
a specific TaqMan Advanced miRNA assay.
Untargeted and targeted metabolomics and lipidomics
Metabolomics and lipidomics will be performed after the
extraction of metabolites and lipids from plasma/serum at
the baseline and final stages of the experiments. Metabo-
lites and lipids will be separated by UPLC and detected by
QTOF and TQP, depending on the procedure. Species
identification will be performed via the PCDL database of
Agilent Technologies, which uses retention times in a
standardized chromatographic system as an orthogonal
searchable parameter to complement accurate mass data
(accurate mass retention time approach). In both cases,
the SMPDB database [38, 39] will be used for querying
metabolites obtained from the HMDB search, using a
0.05 Da M.W. tolerance and the Metaboanalyst platform
[40, 41] for the determination of differential features.
Cardiorespiratory fitness
Cardiorespiratory fitness will be assessed by means of
voluntary maximal graded exercise on a cycle ergometer
(Monark 828E, Monark, Sweden).
Before the exercise test, measures will be taken of
heart rate and systolic (SBP) and diastolic (DBP) blood
pressure, along with a resting electrocardiogram (ECG).
Electrocardiographic leads will be positioned according
to Mason-Likar placement [42].
These tests will be performed at a constant cadence of
60 rpm. The warm-up stage will be 2 min at 10 W (W).
The stepwise graded exercise will then begin, with
increases of 20 W every two minutes until volitional
fatigue or until participants cannot maintain the pre-
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established cadence. The recovery stage will be 3 min
at the load selected by the participant.
During the graded exercise, oxygen uptake and ventila-
tion will be measured using the Oxycon Mobile meta-
bolic system (Oxycon Mobile, Carefusion, Germany).
Gas calibrations will be conducted before each test.
Heart rate will be measured using a Polar 610 s chest
heart rate monitor (Polar Electro YO, Kempele, Finland)
and an electrocardiographic device (Kaunas Load System,
Kaunas, Lithuania).
SBP and DBP will be measured using a manual device
(Omrom M, Omron Healthcare Europe B.V. Hoofddorp,
The Netherlands) at rest, every 2 min during the final
30 s of each stage and at 2, 4 and 6 min of the recovery.
Ratings of perceived exertion (RPE) will be obtained
every 2 min using the 10-point Borg scale [43].
Capillary blood samples (200 μL) from the ear lobe
will be taken at baseline and at the sixth minute of the
post-exercise period for the analysis of plasma changes
due to exertion (miRNA determination and untargeted
and targeted metabolomics and lipidomics).
Data from the exercise test will be recorded for the
screening of abnormal BP and ECG responses, eliciting
either VO2max or VO2peak, as well as for determining
subsequent exercise prescriptions. The criteria for
achieving VO2max will be RER >1.1, a plateau in VO2
(change of <100 mL · min−1 in the final two consecutive
stages), and a HR within 10 beats · min−1 of the max-
imal level predicted by age [7]. Those participants who
do not meet these criteria will be classified as having
reached their VO2peak.
The cycle ergometer test is preferred here to the
treadmill test because it is easier to take the ECG and
BP measurements, and because during the intervention
most of the training sessions will be group indoor cyc-
ling, and hence the transfer of prescribed heart rate will
be more valid. In addition, cycle ergometry is safer than
treadmill testing.
Physical activity habits and sedentary behaviour
Active and sedentary habits will be assessed objectively
by accelerometry using the ActiGraph GT3X+ acceler-
ometer (ActiGraph LLC, Pensacola, FL, USA) over eight
consecutive days. Accelerometers will be positioned lat-
erally on each participant’s waist and attached with an
elastic belt. Participants will be instructed to wear the
accelerometer all day, including during sleep. Acceler-
ometers will be programmed to register the movement
in 60-s epochs and data will be downloaded and ana-
lysed with ActiLife 6.0 software (ActiGraph, Pensacola,
FL, USA). Sleeping hours and 20-min bouts of consecu-
tive zero counts will be excluded from the analysis.
Data from accelerometers will be analysed to yield an
overall physical activity index (expressed as vector
magnitude in mean counts per minute (CPM)) and the
percentage of registered time spent in different levels of
sedentary behaviour or physical activity (PA). The cut-
off points for the categorization of movement intensity
will be defined as follows: sedentary behaviour (SB)
(<100 CPM); light physical activity (LPA) (100 to 2019
CPM) and moderate-to-vigorous physical activity
(MVPA) (>2020 CPM) [44]. Sedentary behaviour will
be assessed as the total time engaged in sedentary
behaviour and as the daily number and length of seden-
tary periods. The assessment of physical activity and
sedentary behaviour will be complemented with a log
of the activities performed during the days on which
participants wear the accelerometers.
Dietary habits
Data regarding participants’ dietary habits will be obtained
using the adult version of the food frequency question-
naire (FFC) [45]. This questionnaire consists of a list of
food groups, with participants being required to indicate
their intake frequency (daily, weekly or monthly) for each
component on the list. This questionnaire has been used
previously in longitudinal dietary studies and in studies
relating dietary patterns and biological parameters in
adults [46].
The Healthy Eating Index [47, 48] will be calculated
to assess and monitor participants’ dietary status. The
Healthy Eating Index (HEI) comprises 10 items, each
representing different features of a healthy diet: items 1
to 5 measure the degree of agreement with national
dietary guidelines for grains, vegetables, fruit, milk and
meat. Items 6 and 7 measure the percentage of total fat
and saturated fat in the total energy intake, items 8 and
9 measure cholesterol and sodium intake, and item 10
examines the variety of the respondent’s diet.
Empowerment and self-efficacy
Empowerment related to health will be measured with
the Spanish version of the Health Empowerment Scale
(HES) [49]. This instrument contains 8 items (self-con-
trol, self-efficacy, problem solving, psychological coping,
stress management, support motivation and decision-
making) that are scored on a 5-point Likert scale rating
from 5 (strongly agree) to 1 (strongly disagree). Higher
scores indicate greater levels of health-related em-
powerment. The Spanish version of the HES achieved a
Cronbach’s alpha (internal consistency) of 0.89, and its
content validity is supported by scale and item content
validity indexes of 0.98 and 1.0, respectively.
Self-efficacy in relation to physical exercise and dietary
habits will be measured with a questionnaire created ad
hoc in accordance with the guidelines of Bandura [50].
This instrument comprises 17 items related to physical
exercise and 10 items related to dietary habits. Each item
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is scored on a 100-point scale ranging, in 10-unit inter-
vals, from 0 (cannot do it at all) to 100 (highly certain I
can do it). Higher scores indicate greater levels of self-
efficacy in relation to exercise and dietary habits.
Health-related quality of life
Health-related quality of life (HRQoL) will be determined
with the Spanish version of the EuroQoL group EQ-5D
questionnaire for adults [51]. The EQ-5D comprises ques-
tions related to five dimensions: mobility, self-care, usual
activities, pain/discomfort and anxiety/depression. Each
dimension has five levels ranging from “no problems” to
“extremely important problems”. The EQ-5D also includes
a vertical visual analogue scale (EQ VAS) on which re-
spondents self-rate their current perception of health be-
tween the endpoints: ‘100 = Best imaginable health state’
and ‘0 =Worst imaginable health state’. The EQ-5D has
shown reliability of 0.86 to 0.90.
Cost analysis
Direct and indirect costs of setting up and running the
interventions will be calculated in order to assess the
economic aspect. HRQoL scores will be used to weight
survival years and, thus, to generate QALYs (Quality
Adjusted Life Years). The cost-effectiveness analysis will
be conducted in accordance with the current practice
methods for economic assessment [52]. The primary
cost-effectiveness outcome will be a reduction in the
metabolic risk score.
Other measures
Demographic and other variables Variables such as
demographic characteristics, personal and family med-
ical history, and medication use will also be registered.
Questionnaires used during the intervention phase
During the intervention phase several questionnaires will
be used to assess the degree of enjoyment with [53] or
the reasons for abandoning the exercise programme.
Data analysis
Timeline of data measurements
Measurements will be taken before (Baseline, t0 = 0 months)
and after (t1 = 16 weeks) the intervention. As a medium-
term follow-up measure, the two intervention groups and
the control group will also be assessed 24 weeks after the
end of the programme (t2).
Data management
Confidentiality will be ensured by coding participants’
personal data, to which only the researchers and health
care professionals will have access.
After randomization, participants will receive an
randomization code (unique for each participant and
blinded for the statistician). All data will be analysed
according to this randomization code. The key to the
source data will only be known by the researchers and
the research coordinator. The researchers will be fa-
miliar with the study procedure, be trained prior to
the study and will collect all data for this study.
Statistical methods
An initial overview analysis will be carried out to detect
any errors and to check the data for normality (Shapiro-
Wilks test), this being done for all participants and inter-
vention groups.
Intention-to-treat (ITT) analysis will be performed
for all recruited participants who complete the baseline
assessment, regardless of whether they subsequently
complete the whole protocol. Missing outcome values
will be replaced by data registered in the previous as-
sessment using the last observation carried forward
(LOCF) technique.
For the baseline comparison of groups we will use the
chi-square test (or Fisher’s exact test) for categorical data
and the analysis of variance (ANOVA) (or Kruskall-Wal-
lis test) for quantitative data (continuous or ordinal). If
significant differences are detected we will use Student’s
t-test (or Mann–Whitney test) for each pair of groups.
For the analysis of the intervention effect two time
frameworks will be established: efficacy (at the end of
the intervention: t1) and durability (at 24-week follow-
up: t2). Change will be calculated as the change from
baseline values, both as absolute values and as a percent-
age adjusted to baseline values. We will adjust repeated
measures techniques to study the general behaviour of
the outcomes in the follow-up.
Continuous variables will be expressed as mean and
standard deviation (SD). Effect size will be estimated as
the mean standardized difference between the mean of
each group divided by the pooled standard deviation. In
accordance with Cohen’s criterion [54], values of 0.2–0.5
represent small differences, 0.5–0.8 moderate differences
and >0.8 large differences. Categorical variables will be
expressed as counts (n) and percentages (%), unless
otherwise specified.
All analyses will be conducted using the Statistical
Package for the Social Sciences (SPSS) v17 (SPSS Insti-
tute Inc., IL, USA) and the level of significance will be
set at p < 0.05.
Risk and burdens
The main expected difficulties are a low adherence rate
and the impossibility of blinding the intervention to
participants and researchers. However, we will seek
to minimize the former by individualizing attention
(providing and discussing written feedback reports)
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during the implementation phase and the latter by
blinding researchers to the group to which individuals
were allocated.
Discussion
In its 2008–2013 action plan the WHO [55] states, among
others, the following aims: a) the promotion of interven-
tions for the prevention and control of the main modifi-
able risk factors for non-communicable disease, b) the
implementation of actions to help individuals to enhance
their self-efficacy, improving literacy and providing tools
for self-control, and c) the promotion of research to estab-
lish the cost/efficacy relationship of these interventions.
We believe that with our study design we focus on these
key aspects.
Current evidence indicates that AIT may be a valuable
physical exercise strategy in terms of improving cardiac
and metabolic risk status, functional capacity and quality
of life [12, 18, 20]. AIT has demonstrated consistently
better results than TCT when it comes to improving
VO2max. Given that the VO2max is associated with pre-
mature mortality and cardiovascular risk [56] the po-
tential ability of AIT to improve this parameter is, from
the health perspective, a promising finding. However,
although the efficacy of AIT to induce physiological im-
provements in a well-controlled research environment
is no longer in doubt, questions remain regarding the
extent to which its benefits are transferable to a less-
controlled clinical environment [21]. A further issue is
that the evidence regarding the effectiveness of more
traditional programmes for promoting physical activity
is also inconsistent [57]. This study aims to address this
issue by evaluating the effectiveness of AIT versus TCT
(both concomitant with lifestyle counselling) as a pri-
mary care intervention for the management of metabolic
syndrome risk factors in low-active adults presenting
one or more of such factors.
A major strength of our study is its design, which will
shed light on the extent to which 1) an AIT programme
is a viable tool for implementation in the primary care
setting, and 2) whether individuals will remain compli-
ant with the programme in the medium term without
supervision. Our study is unique as, unlike other AIT
studies, it considers not only the physical exercise aspect
but also links this to strategies for behaviour change and
empowerment of individuals. According to Biddle [58],
structured physical exercise programmes led by compe-
tent professionals are more effective at encouraging sed-
entary individuals to become more active than are
poorly structured programmes or programmes that are
self-administered at home. However, in order to achieve
long-lasting and successful outcomes these programmes
need to include psychological goals and strategies
(mood, literacy, self-efficacy, social integration) focused
on behaviour change. In this regard, our study includes a
lifestyle counselling intervention that incorporates strat-
egies for promoting regular physical activity, minimizing
sedentary behaviour, improving dietary habits and en-
hancing participants’ self-efficacy. To our knowledge,
this would be the first study in Spain to analyse the ef-
fect of AIT in conjunction with strategies to promote
behaviour change and empower participants.
Another important feature of our study is that, along-
side the assessment of changes in traditional metabolic
risk factors after the intervention, we will also examine its
effect on systemic inflammatory status [5, 59], cardiorespi-
ratory fitness, self-efficacy for physical activity and dietary
habits, empowerment related to health and health-related
quality of life, as well as changes in physical activity levels,
sedentary behaviour and dietary habits.
As noted by Marrugat et al. [60], the most efficient
way of controlling the economic burden of public health
and the mortality rates associated with cardiovascular
diseases is to reduce their prevalence. One of the strategies
for doing so could be the implementation of interventions
designed to promote a healthy lifestyle, but in order to
establish public health priorities it is first necessary to
determine the cost effectiveness of such interventions.
Consequently, the present study, in addition to examining
the effects on physiological, psychological and behavioural
parameters, will also assess the economic impact of the
intervention.
The results of this study will provide insight into the
immediate and medium-term effects on metabolic risk
and lifestyle of the combination of AIT with a multidis-
ciplinary behavioural intervention. If effective, the pro-
posed intervention would provide both researchers and
practitioners in this field with a platform on which to
develop similar intervention programmes for tackling
the repercussions of an unhealthy lifestyle.
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